2018 ATSE Clunies Ross Award Recepients
2018 ATSE Clunies Ross Entrepreneur of the Year: Dr Erol Harvey FTSE TRANSLATING MICRO AND NANO TECHNOLOGY Scientist, educator and entrepreneur Dr Erol Harvey has made outstanding contributions to Australia through the world-leading microfluidic engineering company MiniFAB, his…
Cynata Announces Research Collaboration with University of New South Wales to Develop Stem Cell Therapies for Coronary Artery Disease
Melbourne, Australia; 18 June 2018: Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce that it has commenced a preclinical research collaboration with UNSW Sydney (the University of New South Wales)…
Prana to commence Phase 1 clinical trial of PBT434 for treatment of parkinsonian diseases
Prana receives ethics committee approval for a clinical trial evaluating first in human dosing of PBT434 Recruitment has commenced for the first cohort of healthy volunteers Study conducted by leading Australian early phase clinical trial facility Nucleus Network,…
ASX 100 reaches 30 per cent target but board appointments slow
ASX 200 boards have made substantial progress since 2009 when the percentage of female directors stood at just 8.3%. It now stands at 27.7%. The Australian Institute of…
“Medicines Development for Global Health Secures U.S. FDA Approval For Moxidectin For The Treatment Of River Blindness”
MELBOURNE, GENEVA, and NEW YORK Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved moxidectin 8…
Piper Alderman Melbourne has relocated
From 4 June 2018 you will find them at Level 23, 459 Collins Street, Melbourne, 3000 Commencing Monday 4 June 2018, the Melbourne office of Piper Alderman will operate from Level 23, 459 Collins Street, Melbourne. This change will see…
Member news: Success story of a patient on GrunBiotic’s Neurofolin
Member news: Success story of a patient on GrunBiotic’s Neurofolin: https://www.mamamia.com.au/folate-depression/”
AdAlta secures key manufacturing agreements for AD-214
AdAlta secures key manufacturing agreements for AD-214 Please click here for an ASX announcement relating to the execution of key manufacturing agreements for AD-214
Walter and Eliza Hall Institute news: Structure of protein pair provides blueprint for future drugs
Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling to dampen immune responses and block cancer growth. The atomic-level structure of SOCS1 binding to its partner protein…
Women Leading World-Class Health Innovation in Melbourne
Victoria grows globally competitive innovation-intensive companies. Innovation is a people-driven process that thrives on diverse thinking and views. Now that business is embracing the performance-based argument, successful women in and those aspiring towards leadership roles need recognition to…
Australia is backing health innovation industries to build future economy
Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…
New BioMelbourne Network Board Appointment – David Herd
The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting. “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…
